SPOP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.631600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.990400E-01
Normal-vs-Stage2
2.283800E-01
Normal-vs-Stage3
9.126500E-02
Normal-vs-Stage4
5.295000E-01
Stage1-vs-Stage2
3.686400E-01
Stage1-vs-Stage3
9.948200E-02
Stage1-vs-Stage4
9.199600E-01
Stage2-vs-Stage3
1.494780E-01
Stage2-vs-Stage4
5.286200E-01
Stage3-vs-Stage4
1.390590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.753400E-01
Normal-vs-AfricanAmerican
5.163800E-01
Normal-vs-Asian
2.640500E-02
Caucasian-vs-AfricanAmerican
6.481400E-01
Caucasian-vs-Asian
8.889800E-02
AfricanAmerican-vs-Asian
1.007370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.589200E-01
Normal-vs-Female
2.833800E-01
Male-vs-Female
6.813400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.023600E-01
Normal-vs-Age(41-60Yrs)
5.321200E-01
Normal-vs-Age(61-80Yrs)
1.906960E-01
Normal-vs-Age(81-100Yrs)
8.716000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.179600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.112000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.618000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.048310E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.510620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.855600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.877600E-02
Normal-vs-Daily Drinker
6.026200E-02
Normal-vs-Weekly Drinker
7.859900E-02
Normal-vs-Occasional Drinker
5.719000E-01
Normal-vs-Social Drinker
8.650400E-01
Non Drinker-vs-Daily Drinker
8.252600E-01
Non Drinker-vs-Weekly Drinker
7.366400E-01
Non Drinker-vs-Occasional Drinker
1.775570E-02
Non Drinker-vs-Social Drinker
2.910000E-02
Daily Drinker-vs-Weekly Drinker
8.994800E-01
Daily Drinker-vs-Occasional Drinker
5.074300E-02
Daily Drinker-vs-Social Drinker
4.342200E-02
Weekly Drinker-vs-Occasional Drinker
1.094400E-01
Weekly Drinker-vs-Social Drinker
6.367800E-02
Occasional Drinker-vs-Social Drinker
5.827200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.011620E-01
Normal-vs-Grade 2
6.971900E-02
Normal-vs-Grade 3
6.005800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.215400E-01
Grade 1-vs-Grade 3
1.138630E-01
Grade 1-vs-Grade 4
1.011620E-01
Grade 2-vs-Grade 3
3.936600E-01
Grade 2-vs-Grade 4
6.971900E-02
Grade 3-vs-Grade 4
6.005800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.034800E-01
Normal-vs-NonDiabetic
1.949550E-01
Diabetic-vs-NonDiabetic
5.434600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.282200E-01
Normal-vs-NoPancreatitis
1.828800E-01
Pancreatitis-vs-NoPancreatitis
8.791600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.180600E-01
Normal-vs-N1
2.437000E-01
N0-vs-N1
8.803000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.694400E-01
Normal-vs-TP53-NonMutant
6.590600E-01
TP53-Mutant-vs-TP53-NonMutant
5.278000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
